Pre-Treatment With Glucagon-Like Peptide-1 Protects Against Ischemic Left Ventricular Dysfunction and Stunning Without a Detected Difference in Myocardial Substrate Utilization-Reference-Cited by-同舟云学术

Pre-Treatment With Glucagon-Like Peptide-1 Protects Against Ischemic Left Ventricular Dysfunction and Stunning Without a Detected Difference in Myocardial Substrate Utilization

Published:2015-02 Issue:2 Volume:8 Page:292-301
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

McCormick Liam M.,Hoole Stephen P.,White Paul A.,Read Philip A.,Axell Richard G.,Clarke Sophie J.,O’Sullivan Michael,West Nick E.J.,Dutka David P.

Funder

Medical Research Council

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference33 articles.

1. The physiology of glucagon-like peptide 1;Holst;Physiol Rev,2007

2. Biology of incretins: GLP-1 and GIP;Baggio;Gastroenterology,2007

3. Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways;Ban;Circulation,2008

4. Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury;Bose;Diabetes,2005

5. Glucagon like peptide-1 is protective against myocardial ischemia/reperfusion injury when given either as a preconditioning mimetic or at reperfusion in an isolated rat heart model;Bose;Cardiovasc Drugs Ther,2005

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypothermia for Cardioprotection in Acute Coronary Syndrome Patients: From Bench to Bedside;Journal of Clinical Medicine;2024-09-12

2. Strategies for chronic coronary disease: A brief guide for clinicians;npj Cardiovascular Health;2024-06-04

3. Anti-Inflammation and Anti-Oxidation: The Key to Unlocking the Cardiovascular Potential of SGLT2 Inhibitors and GLP1 Receptor Agonists;Antioxidants;2023-12-20

4. Potential Role of GLP-1 Based Therapeutics in Coronary Artery Disease;Frontiers in Bioscience-Landmark;2023-11-29

5. Research progress on the effects of novel hypoglycemic drugs in diabetes combined with myocardial ischemia/reperfusion injury;Ageing Research Reviews;2023-04